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ABSTRACT 
Relationship of Global DNA Methylation with Cardiovascular Fitness and 
Body Composition 
by 
Michael Steele Jarrett 
James Navalta, Examination Committee Chair 
Associate Professor of Kinesiology 
University of Nevada, Las Vegas 
 
 
Background:  Global DNA Methylation (GDM), an epigenomic modification has 
been linked to the development of Cardiovascular Disease and its risk factors.  
Purpose: The purpose of this study was to determine if there is a significant 
correlation between GDM and cardiovascular fitness, as well as, measures of 
body composition. Methodology: 26 apparently healthy, adults (11 males) 
completed a physical activity and diet questionnaire, as well as, had a small 
blood sample (600μL) collected via finger prick for the determination of GDM. 
Body composition was assessed by means of a Dual-Energy X-ray 
Absorptiometry (DEXA) scan, while cardiovascular fitness was evaluated by the 
completion of a maximal exertion, graded exercise test (VO2max) on a treadmill.  
Peasron’s “r” value was used to determine the correlation GDM and various 
variables, while t-tests were used to determine if any differences between high 
and low value groups for each variable existed. Results: Body Mass Index was 
significantly correlated (p-value, r value; 0.031, -.556) with GDM while there was 
a significant difference between high and low level folate groups (p=0.034) as 
determined by the diet questionnaire.  No significant correlations or differences 
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were found in males.  Conclusion: The results conclude that as BMI increases, 
GDM decreases in females.  In attempts to further investigate the relationships 
between GDM and these variables, auxiliary research needs to be conducted 
with larger subject pools containing additional sedentary participants.  
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CHAPTER 1 
 
INTRODUCTION 
 The culmination of the Human Genome Project in 2003 caused a giant 
expansion in the field of genomics research.  It is understood that genomics is 
the study of the 3 billion base pair long chain of genetic information known as the 
genome.  A multitude of research has investigated numerous aspects of the 
genome and how it relates to the physical outcome or creation of a being.  
Throughout this research, it has become apparent that other factors must interact 
with or affect the genome in order to account for the mass variance in genomic 
expression (Ordovas & Smith, 2010).  It is this mindset that contributes to the 
field of study known as epigenomics. 
 Epigenomics is the study of heritable alterations in gene expression potential 
that are not caused by changes in the actual DNA sequence (Waterland, R. A., 
2009).  These alterations to the genome result in differences to the future 
outcome or expression of the genetic information, one possible reason why some 
genes are recessive and others are dominant.  To date, there are three main 
mechanisms that are attributed to epigenomic alterations: 1) DNA methylation, 
considered the primary measure, 2) histone modification, and 3) autoregulatory 
proteins that add in modification (Waterland, R. A., 2009). 
 A plethora of research on the effects of DNA methylation on health issues and 
outcomes has been conducted since the early 2000’s, with the majority of the 
research focusing on links to cancer (Choi et al., 2009), (Das and Singal, 2004).  
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Nearly ten times more research has been published concerning DNA methylation 
and cancer than the relationship of DNA methylation and cardiovascular disease 
(31,306 articles vs 3,848 articles on PubMed respectively).  More recent studies 
such has the investigation conducted by Kim et al., 2010 are now turning their 
attention to the connections between DNA methylation and cardiovascular 
disease (CVD) with the possibility of creating a new biomarker for the detection 
of CVD.  Risk factors for CVD such as obesity, smoking, and nutritional status 
have been investigated and were found to correlate with DNA methylation 
(Ordovas and Smith, 2010).  Breton et al (2009) noted that children that were 
exposed to smoking prenatally, had significantly (p=0.03) lower methylation 
levels at the AluYb8 gene.  Similarly, Ong, Moreno, and Ross (2012) investigated 
the multitude of research that examines the relationship between bioactive food 
components (BFC), those components that have anticancer potential, and global 
DNA methylation.  A unanimous finding of global DNA hypomethylation was 
noted in those that consumed the anticancer components (Ong, Moreno, and 
Ross, 2012). 
 
 Not all risk factors for CVD have been investigated thoroughly however.  The 
amount of information concerning the relationship between physical inactivity 
and/or exercise and DNA methylation is considerably less than that of other CVD 
risk factors.  Recent PubMed searches revealed 4,224 articles concerning “DNA 
methylation and nutrition”, while only 2,764 articles were found dealing with “DNA 
methylation and obesity” and a mere 1,235 articles that remotely related to “DNA 
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methylation and exercise”.  With this in mind, it is imperative that research be 
conducted on this relationship to determine whether it follows suit with obesity, 
smoking, and nutritional status.  More importantly, the results of this research 
could aid in providing evidence to use DNA methylation as a biomarker for CVD 
and its predecessors/risk factors. 
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Purpose of the Study 
The purpose of this study is to determine if there is a correlation between 
cardiovascular fitness level, as determined by maximal oxygen consumption, and 
level of global DNA methylation.  Additionally, the study will investigate the 
relationship between percent body fat and Global DNA methylation. 
 
Research Hypotheses 
Hypothesis #1 
H01: There will be no correlation between cardiovascular performance measures 
and global DNA methylation level. 
HA1: There will be a correlation between cardiovascular performance measures 
and global DNA methylation level obtained from isolated white blood cells. 
Hypothesis #2 
H02: There will be no correlation between body composition and global DNA 
methylation level. 
HA2: There will be a correlation between body composition measures and global 
DNA methylation level obtained from isolated white blood cells. 
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Significance of the Study 
The significance of this study lies in the possibility of finding a link between 
cardiovascular fitness level, as well as body composition, and the biomarker 
known as global DNA methylation.  Finding a significant connection between 
these variables will provide evidence and rational for using global DNA 
methylation as a new quantitative risk factor for cardiovascular disease. 
 
 
Definition of Terms 
The following definitions are given for the purpose of clarification: 
Cardiovascular Disease (CVD) – An umbrella term used to describe any health 
issue concerning the heart, blood vessels, or cardiovascular system as a whole. 
Includes but not limited to: myocardial infarction, cerebrovascular accident, and 
hypertension.  
CpG Island – The pairing of cytosine and guanine to form a dinucleotide. This 
dinucleotide is a base pair in the formation of DNA. 
DNA – Deoxyribonucleic Acid 
DNA Methlyation – The addition of a methyl group to the 5 position of cytosine in 
a CpG island. 
Epigenome – Any factor that effects genetic expression without directly modifying 
or altering the genome. 
Genome – An organism’s complete set of DNA or hereditary information. 
Genomics – The study of the genome as a whole. 
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Global DNA Methylation (GDM) – The amount of methylation across the entire 
genome, expressed as a percentage. 
VO2max – The maximal amount of oxygen that an individual and uptake and utilize 
for energy production. 
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CHAPTER 2 
 
REVIEW OF RELATED LITERATURE 
 As previously mentioned, the amount of published research concerning DNA 
methylation and cardiovascular disease as well as its risk factors is relatively 
small in size and scarce in quantity.  Despite this fact, key relationships and 
observations have been noted.  The remainder of this review of literature will 
focus on these findings including the different epigenomic markers, the 
relationship between DNA methylation and cardiovascular disease, the link 
between DNA methylation and obesity, and the influence of exercise on DNA 
methylation. 
Epigenomic Markers 
 There are three primary mechanisms that are responsible for epigenetic and 
epigenomic modifications: 1) DNA methylation, considered the primary measure, 
2) histone modification, and 3) autoregulatory proteins that add in modification 
(Waterland, R. A., 2009).  Most of the current literature on epigenomic 
modification utilizes DNA methylation as the indictor of alteration.  The rationale 
for this is twofold: 1) DNA methylation is the easiest epigenomic modification to 
test for on both a genetic and genomic level, 2) both histone modification and 
autoregulatory proteins effect DNA methylations.  This section of the literature 
review will summarize how each epigenomic mechanism functions. 
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DNA Methylation 
    DNA methylation is the process in which a methyl group is added to a CpG 
dinucleotide within the genome (see Figure 2.1).   
 
Figure 2.1: DNA Methylation at CpG Dinucleotide (Kim et al., 2011)  
 
 
 
This process is outlined in detail by Baccarelli & Ghosh (2012), beginning with 
the actions of a cohort of enzymes known as the DNA methyl transferases 
(DNMTS: DNMT1, DNMT3a, and DNMT3b).  One of the DNA methyl transferase 
enzymes interacts with S-adenosylethionine (SAM) and detaches a single methyl 
group for it, converting SAM into S-adenosylhomocysteine (SAH) (see Figure 
2.2).  The free methyl group is then attached to the 5th position on a CpG 
dinucleotide.  This CpG dinucleotide is more commonly referred to as a CpG 
island, and will be referred to as such for the remainder of this paper. 
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 Figure 2.2 CpG Methylation 
Courtesy of Dr. Amr Sawlha, University of Michigan  
 
 
 
 Methylation can occur at any CpG island within the genome.  The location of 
the CpG island determines what effect the methyl group will have on the 
genome.  If the CpG island is located within a coding or promoter region of a 
gene, then the transcription of that gene will most likely be repressed.  This is 
due to the fact that the methyl group interferes with the binding of transcription 
factors.  It should be noted that only 10% of all methylated CpG islands are 
located within a coding region (Baccarelli & Ghosh, 2012) 
 It is unclear at this point in time why this process (methyaltion) takes place, 
but studies have shown trends and relationships between methylation levels and 
health complications including atherosclerosis and various forms of cancer 
(Stauffer & DeSouza, 2010).  Additionally, multiple stimuli (i.e. diet and habitual 
activities) have been linked with abnormal (hyper or hypo) levels of methylation 
(Stauffer & DeSouza, 2010).  These trends and relationships will be discussed in 
the latter portions of this paper. 
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Histone Modification 
 The second epigenomic mechanism is known as histone modification.  
Histones are spool-like protein formations in which 146 base pairs of DNA are 
wrapped around.  There are comprised of 4 major proteins (H2A, H2B, H3, and 
H4) and an unstructured N-terminal tail (Mazzio and Soliman, 2012).  The main 
function of a histone is to assist in packaging DNA into chromosomes by the 
formation of nucleosomes (histones wrapped in DNA).  Histones are modified 
when one of six different actions (methylation, acetylations, phosphorylation, 
ubiquitination, biotinylation, sumoylation, and proline isomerization) occurs on the 
N-terminal tail.  This modification to the tail is known as a histone mark.  The 
histone mark can cause gene repression or silencing by adjusting how “tightly” 
the DNA strand is wound around the histone (see Figure 2.3).  
 
 
Figure 2.3: Histone Modification Causing Gene Silencing 
Courtesy of the National Human Genome Research Institute  
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Assistant Proteins 
 
 The final major mechanism of epigenomics does not directly alter a genes 
expression per se but does assist in the modification of that gene.  There are 
certain proteins that interact with the chromatins and nucleosoms, causing 
structural alterations that either allow or deny further DNA methylation or histone 
modification.  There are three primary categories of assistant proteins: 1) 
chromatin remodeling complexes, 2) effector proteins with various binding 
modules for different modifications, and 3) insulator proteins (Kim, 
Samaranayake, & Pradhan, 2009). The complete explanation and discussion of 
the assistant protein is outside the scope of this paper.  The following is a brief 
explanation of the three primary types of assistant proteins and how their 
functions contribute to epigenomic modification. 
 The primary function of chromatin remodeling complexes are to grant access 
to certain regions of DNA or histones by the use of nucleosomal repositioning, 
histone-DNA interactions, and histone octamer positioning (Kim, Samaranayake, 
& Pradhan, 2009).  Chromatin remodeling complexes are unique in that they 
require ATP to accomplish their function.  In the diagram below (Figure 2.4, A), a 
chromatin remodeling complex is altering the position of a nucleosome through 
an energy-driven reaction.  The resulting repositioning allows access to a specific 
DNA location that was previously hidden to epigenetic modifiers. 
 Effector proteins can assist chromatin remodeling complexes in the 
repositioning of histones and chromatins.  Additionally, effector proteins can 
serve as a marker for chromatin-modifying enzymes or remodeling complexes 
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(Kim, Samaranayake, & Pradhan, 2009).  Marking the histone or chromatin in 
this way can cause additional modification enzymes that would normally not 
affect the area, to bind to the area and cause alterations.  Figure 2.4B 
demonstrates this mechanism by using the example of effector protein HP1.  
Normally, the enzymes DNMT and SUV39H1 would not affect the histones, but 
HP1 has marked the location and is serving as an adaptor to allow DNMT and 
SUV39H1 to attach.  This allows DNMT and SUV39H1 to modify the histones, 
increasing the amount of methylation. 
 Insulators are the final category of assistant proteins and are DNA elements 
that serve as boundary markers on throughout the genome.  These markers 
segregate genes in order to prevent incorrect or unwanted repression or 
activation of genes.  As depicted in Figure 2.4C, the insulator (I) can act as an 
enhancer blocking, preventing the activation of a promoter by the hindering the 
access of an enhancer (E).  Additionally, insulators (I) can block off entire 
chromatins and act as a barrier that prevents methylation from neighboring 
chromatins. (Kim, Samaranayake, & Pradhan, 2009)  
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Figure 2.4: Depiction of various assistant proteins. 
Courtesy of Kim, Samaranayake, & Pradhan (2009) 
 
 
 
DNA Methylation and Cardiovascular Disease 
 With an understanding of the significance of DNA methylation in mind, it is 
imperative its link with disease be both evaluated and clearly understood.  
Initially, most of the research in DNA methylation patterns was geared towards 
cancer and tumor development while more recent research has been focused on 
DNA methylation and cardiovascular disease risk and development.  As with 
most research, animal models were used initially to determine if research on the 
topic was necessary.  Lund and associates used a rodent model in 2004 to 
evaluate DNA methylation patterns in mice lacking apolipoprotein E (apoE-) 
versus their control counterparts (Lund et al., 2004).  The apoE– group was 
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predisposed to developing atherosclerosis while the control group consisted of 
normal mice.  Both groups were monitored for six months, with blood and aorta 
tissue sample collected at four weeks and again at six months.  All samples were 
evaluated for global DNA methylation using a DNA fingerprinting technique.  At 
the four week time point, blood analysis did not reveal any significant difference 
in DNA methylation patterns between the two groups.  However, aorta tissue 
sample in the apoE- mice were found to have significantly different (p<0.04) 
methylation patterns compared to the control group.  These patterns consisted of 
both hyper and hypomethylation.  Samples were taken again after 6 months of 
observation.  Both the blood and aorta tissue samples revealed a significant 
difference (p<0.02, p<0.003 respectively) when comparing the apoE- group and 
the control group.  Again, the revealed patterns were of hyper and 
hypomethylation levels in the apoE- group.  Additionally, fibrocellular lesions were 
found in the apoE- group, suggesting the development of atherosclerosis.  While 
the results were somewhat inconclusive in how atherosclerosis causes a 
modification in global DNA methylation, they do offer the conclusion that global 
DNA methylation is significantly altered with the development of atherosclerosis.  
(Lund et al., 2004) 
 Similar, yet more conclusive findings were brought about by a study 
conducted by Stenvinkel et al (2007), in a human model similar to the mouse 
model used by Lund et al (2004).  Stenvinkel and associates investigated the 
association between DNA methylation and cardiovascular disease development 
in chronic kidney disease (CKD) patients and disease-free control group.  CKD 
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patients were chosen as the experimental group due to their increased risk of 
developing cardiovascular disease.  Both CKD (n = 155) and control (n = 36) 
groups were evaluated for global DNA methylation by blood sample as well as 
signs of cardiovascular disease (inflammation and oxidative stress biomarkers) 
for 36 months.  The global DNA methylation levels of CKD patients (n=62) that 
developed chronic inflammation (determined by IL-6 and C-reactive protein 
levels) were compared to those of the control group.  It was found that the CKD 
patients with inflammation had significantly (p<0.001) increased levels of 
methylation.  It is noted that the CKD patients that did not present with 
inflammation had methylation levels similar to the control group.  These results 
indicate that those patients that were developing cardiovascular disease 
presented elevated global DNA methylation levels, leading the authors to 
suggest that cardiovascular disease is associated with hypermethylation at the 
genomic level (Stenvinkel et al., 2007). 
 While the above mentioned study used a similar model with a control group, 
Kim and associates published comparable results with a population based study 
in 2010.  Kim et al (2010) evaluated the global DNA methylation and 
cardiovascular disease status of 286 males and females out of a 63,257 
population based cohort in Singapore over 5 years.  The subjects presented at 
baseline for blood draws and cardiovascular disease and disease risk evaluation.  
Out of the 286 subjects, 101 present with cardiovascular disease at baseline.  All 
subjects reported back for a follow-up visit 5 years later.  From the remaining 185 
subjects, 52 presented cardiovascular disease at the second visit.  All subjects 
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with cardiovascular disease (n = 153) were compared to remaining disease-free 
subjects (n = 133) on the basis of global DNA methylation levels.  The results did 
not show a significant difference for the population as a whole but was further 
separated by gender, revealing significant results.  Males that presented with 
cardiovascular disease had significantly (p <0.05) elevated global DNA 
methylation levels compared to their disease-free counterparts, while females 
were not significantly different.  These finding were in agreement with Stenvinkel 
et al (2007).  (Kim et al., 2010) 
 
Table 2.1 Summary of DNA Methylation and Disease Research 
Article Subjects 
Dependent 
Variable 
Independent 
Variable/s Results 
Lund et al. 
(2004) 
n=27 mice GDM 
Prevalence of 
atherosclerosis 
↑ GDM  
     
Stenvinkel 
et al. 
(2007) 
n=191 
males & 
females 
GDM 
Inflammation 
measured by 
IL-6 and C 
↑ GDM in patients 
with inflammation 
     
Kim et al. 
(2010) 
n=286 
males & 
females 
GDM CVD 
↑ GDM in CVD 
patients 
GDM – Global DNA Methylation, CVD – Cardiovascular Disease 
 
 
DNA Methylation and Obesity 
 At this point in time, global DNA methylation seems to be closely correlated 
obesity as calculated by body mass index (BMI) or an individual’s weight in 
kilograms divided by their height in meters squared (Kim et al., 2010).  Upon the 
examination of 286 men and women from Singapore, it was found that those with 
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a BMI value of 24 kg/m2 or higher had significantly  (p = 0.007) elevated levels of 
global DNA methylation compared to those with a BMI value lower than 24 kg/m2.  
 These results are in agreement with data collected by both Wang et al (2010) 
and Milagro et al (2012) in which the methylation status of individual genes were 
examined.  Wang et al (2010) found obese (BMI > 30 kg/m2) individuals 
displayed significantly (p = 0.008) higher methylation levels in the Ubiquitin- 
Associated and SH3 domain-containing protein A (UBASH3A) gene compared to 
non obese individuals.  Likewise, Milagro et al (2012) found that 
overweight/obese individual had elevated methylation levels of the circadian 
clock system (internal clock) gene, CLOCK 1, compared to lean individuals 
(17.4% compared to 12.4% respectively). 
 Though evidence displayed above gives insight to the relationship between 
obesity and DNA methylation levels, it does not take individual’s percentage of 
fat mass into consideration.  All three of the aforementioned studies used BMI as 
their stratification tool for obesity, there by not actually measuring the amount of 
fat mass or fat-free mass.  One study conducted by Fermin et al (2011) did go a 
step further than BMI and measured body composition by means of bioelectric 
impedance analysis.  Fermin et al (2011) set out to determine whether or not 
methylation levels of nine obesity-related genes (AQP9, ATP10A, CD44, IFNG, 
MEG3, NTF3, POR, TNFRS9, and WT1) could be used to predict weight loss 
and body composition responses to a hypocaloric diet.  The study was conducted 
on twenty-five (n=25) overweight or obese (BMI M (SD): 30.5 (0.45) kg/m2)) men.  
Anthropomorphic measurements (Height, weight, age, percent body fat, and 
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waist girth) and blood samples were taken prior to and following an eight week 
hypocaloric diet.  DNA methylation levels were measured in peripheral blood 
mononuclear cells obtained by the blood samples.  Two (ATP10A and CD44) out 
of the nine genes studied were found to be significantly related with the loss of fat 
mass, the amount of weight lost and changes in waist girth.  Figure 2.5 presents 
the relative data on the relationship between the methylation levels of CpG 
islands within the ATP10A gene and weight loss, changes in fat mass, and 
changes in waist girth.  Similarly, Figure 2.6 discusses the significance changes 
of the same factors in relation to methylation levels at CpG islands within the 
CD44 gene.  These results allude to two relative concepts: 1) DNA methylation at 
a genetic level is significantly correlated with changes in fat mass, over-all 
weight, and changes in waist girth 2)  DNA methylation (ATP10A and CD44 
genes specifically) could be used to predict an individual’s degree of response to 
a hypocaloric diet. 
 While Fermin et al (2011) did not specifically investigate GDM alteration with 
weight or fat loss, their data does coincide with the aforementioned studies (Kim 
et al., (2010); Wang et al., (2010); and Milagro et al., (2012)) in that it 
demonstrates a relationship between DNA methylation and obesity.  Additionally, 
it supports the notice of using DNA methylation as a predictor of CVD risk factors 
and responses to lifestyle alterations. 
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Figure 2.5: ATP10A Results 
Relationships between baseline methylation levels of CpG Islands within the ATP10A gene and 
weight loss, fat mass change, BMI change and waist girth change. (Fermin et al., 2011) 
 
 
 
 
 
Figure 2.6: CD44 Results 
Relationships between baseline methylation levels of CpG Islands within the CD44 gene and weight 
loss, fat mass change, BMI change and waist girth change. (Fermin et al., 2011) 
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Table 2.2 Summary of DNA Methylation and Obesity Research 
Article Subjects 
Dependent 
Variable 
Independent 
Variable/s Results 
Kim et 
al. 
(2010) 
n=286 
males & 
females 
GDM BMI 
↑ GDM in obese 
individuals 
     
Wang et 
al. 
(2010) 
n=92 
males & 
females 
UBASH3A gene 
methylation 
BMI 
↑ Methylation in 
obese individuals 
     
Milagro 
et al. 
(2012) 
n=60 
females 
CLOCK 1Gene 
Methylation 
BMI 
↑ Methylation in 
obese individuals 
     
Fermin 
et al. 
(2011) 
n=25 
males 
Methylation 
levels of 9 
obesity –related 
genes 
BMI changes 
with 
hypocaloric 
diet 
CD44 and ATP10A 
are related with ↓ in 
weight/fat 
mass/waist girth 
BMI – Body Mass Index, GDM – Global DNA Methylation 
 
 
DNA Methlyation and Exercise 
 The relationship between DNA methlyation and exercise has not been 
examined in great detail.  Recent database searches have yielded minimal 
findings, resulting in only a hand full of articles pertaining to the topic.  
Additionally, the available findings are contradictory with reports of both 
increasing and decreasing in methylation levels. 
 One study conducted by Zhang et al (2011) examined the relationship 
between physical activity levels of cancer-free adults (ages 45-75 years old) and 
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their global DNA methylation level.  Participants gave a baseline blood sample at 
the beginning of the study and wore accelerometers for 4 days (3 weekdays and 
1 weekend day) to determine their level of physical activity.  It was observed that 
individuals that were physically active for 26-30 minutes per day had significantly 
higher levels of global DNA methlyation compared to those who were active for 
less than 10 minutes per day (β = 2.52, 95% CI: 0.70, 4.35).  Simple linear 
regression failed to be significant, negating the idea of a dose-response 
relationship between the two variables.  These findings suggest that individuals 
that achieve the recommended amount of physical activity per day are 
hypermethylated compared to sedentary individuals. (Zhang et al., 2011) 
 While the above mentioned study demonstrated an elevated level of 
methylation on a genomic level, results from Barres and associates revealed 
differences on a genomic as well as a genetic or per gene basis.  Barres et al 
(2012) examined the acute effects of a single bout of exercise on DNA 
methylation levels in healthy, sedentary men and women (n=14).  Blood samples 
were taken before and after a peak pulmonary oxygen uptake rate test on a 
magnetically braked cycle ergometer.  The results of a paired t-test showed a 
significant (p < 0.05) decrease in global DNA methylation after the exercise bout.  
Additionally, individual genes associated with metabolic and structural functions 
in skeletal muscles (PGC-1a, TFAM, PPAR-d, PDK4, citrate synthase [CS]) were 
examined and found to have decreased methylation levels following the cycle 
test.  These results seem to contradict the hypermethylation findings of Zhang et 
al (2011). 
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 To further investigate the effects of acute exercise on DNA methylation, 
Barres et al (2012) looked at a subgroup (n=8) of the original 14 participants and 
had them complete two additional exercise sessions in the following days after 
the VO2max tests.  The additional exercise sessions were completed on separate 
days with at least one week in between the trails.  Each exercise session was 
conducted on the same cycle ergometer and was at varying intensities (40% or 
80% of aerobic capacity).  Blood samples after each exercise session were 
evaluated for changes in DNA methylation of the previously mentioned genes.  It 
was found that the low intensity (40% aerobic capacity) exercise did not alter 
methylation levels compared to resting values, while high intensity (80% aerobic 
capacity) exercise decreased methylation values (p < 0.05).  These results are 
again contradictory to Zhang et al (2011) and suggest that a dose response 
relationship may exist between exercise and gene methylation levels.  (Barres et 
al., 2012) 
 Though global DNA methylation was not measured, Nakajima et al (2009) 
does add to the research compendium by displaying earlier findings of exercise 
inducing hypermethylation of the ASC (Apoptosis-associated Speck-like protein 
containing a Caspase recruitment domain) gene in older men.  The research 
group set out to evaluate the effects of chronic exercise on the methylation levels 
of the ASC gene that is responsible for the production of pro-inflammatory 
cytokines.  A total of 383 older (40-87 years of age) males were divided into 
either and exercise (n = 230) or a control (n = 153) group.  The exercise group 
completed bouts of high-intensity interval walking (3 minutes of 40% peak 
 23 
 
 
aerobic capacity followed immediately by 3 minutes of walking at 70% peak 
aerobic capacity) every day for 6 months.  Blood samples were taken at the 
completion of the 6 months and tested for methylation of the ASC gene.  The 
exercise group had significantly (p<0.01) higher methylation values for the ASC 
gene compared to the control group.  This lead to the researchers to conclude 
that exercise induces hypermethylation of the ASC gene in older males, thereby 
decreasing the production of pro-inflammatory cytokines. (Nakajima et al., 2009) 
 
 
Table 2.3 Summary of DNA Methylation and Exercise Research 
Article Subjects 
Dependent 
Variable 
Independent 
Variable/s Results 
Zhang et 
al (2011) 
n=161 
males 
females 
GDM 
4 day physical 
activity level 
↑ GDM 
     
Barres et 
al (2012) 
n=14 
males & 
females 
GDM, PGC-1a, 
TFAM, PPAR-d, 
PDK4, and citrate 
synthase 
methylation 
Exercise (peak 
pulmonary oxygen 
uptake test) 
↓Methylation of 
all 
measurements 
     
Barres et 
al (2012) 
n=8 
males 
PGC-1a, TFAM, 
PPAR-d, PDK4, 
and citrate 
synthase 
methylation 
Excise Intensity 
(40% and 70% 
aerobic max) 
↓Methylation 
with ↑exercise 
intensity 
     
Nakajima 
et al 
(2009) 
n=383 
males 
ASC Gene 
Methylation 
6 month walking 
program 
↑ ASC 
Methylation 
GDM – Global DNA Methylation 
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CHAPTER 3   
 
METHODS 
Participant characteristics 
 Participants were apparently healthy male and female adults between the 
ages of 21-39 years old (n=26).  Apparently healthy was defined as receiving a 
passing score on the Modified American College of Sports Medicine 
Health/Fitness Facility Pre-participation Screening Questionnaire. 
 
Table 3.1 Participant Characteristics 
   Males Females 
N 11 15 
Height (cm) 
175.7 ± 7.8 
163.9 ± 
6.3 
Weight (kg) 85.0 ± 15.4 
60.0 ± 
7.6 
Age (years) 25.6 ± 5.2 
26.8 ± 
4.8 
BMI 
27.4 ± 3.6 
22.3 ± 
2.2 
Body Fat (%) 20.0 ± 6.2 
26.0 ± 
7.5 
 
 
Collection of the Data 
Preliminary Data 
 Prior to the visit, participants were instructed to wear appropriate fitness 
clothing (i.e. running shoes, lose shirt, and shorts), to be well hydrated and to not 
consume any substance with calories 2 hour prior to their visit.  Additionally, the 
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participants had been instructed to refrain from consuming alcohol and from 
exercising for at least 6 and 24 hours prior to their test respectively. 
 Upon arrival to the Exercise Physiology Laboratory, the participants were fully 
informed about the purpose, requirements, procedures, risks, and benefits of the 
study and were asked to sign an informed consent document that had been 
approved by the UNLV Institutional Review Board (Protocol #: 1209-4268).  The 
participants then completed the Modified American College of Sports Medicine 
Health/Fitness Facility Pre-participation Screening Questionnaire.  Participants 
were permitted to continue the study only if they received a passing score on the 
health questionnaire.  Afterwards, each participant was assigned a subject 
identification number and basic anthropomorphic measurements were taken 
including height, weight, age, and body composition as determined by dual 
energy x-ray absorptiometry.  In order to control for the effects of diet and 
lifestyle choices on methylation levels, each subject completed a food frequency 
questionnaire dealing with folate-rich foods as well as a physical activity 
questionnaire. 
Graded Exercise Test 
 Participants completed a graded exercise test (GXT).  The GXT was 
conducted on a treadmill using two minute stages.  The participants walked at a 
self-selected speed with no incline for two minutes, followed by jogging for two 
minutes at a self-selected speed with no incline.  The incline of the treadmill was 
increase by 2% grade every two minutes while remaining at the same jogging 
speed, until volitional fatigue. Before beginning the GXT, the participants were 
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instructed on how to use the Borg Ratings of Perceived Exertion scale (RPE).  
The GXT was terminated when the participant could no longer continue or if the 
participants wished to stop.  Heart rate and oxygen uptake were measured 
continuously throughout the test by a Moxus Metabolic System (AEI 
Technologies, Pittsburgh, PA).  The participant’s RPE score was evaluated at the 
end of every stage.  Participants’ VO2max values were determined by averaging 
the two highest, consecutive values in a 30 second rolling average of VO2 
(ml/kg/min).  The time period used for the rolling average was defined as the 
period in which the participant had achieved two of the following criteria: heart 
rate ≥ 90% of their age predicted max, a respiratory exchange ratio at or above 
1.05, an RPE ≥ 19, or their VO2 (ml/kg/min) value had plateaued despite an 
increase in exercise intensity. 
Blood Sample Collection 
 Upon completion of the informed consent and health screening questionnaire, 
a sample of blood (600 µl) was obtained from the participant via finger-stick using 
antiseptic technique into an anticoagulant tube (Multivette 600 LH, Sarstedt, 
Fisher Scientific, Pittsburgh, PA).  The blood draw site was cleaned with an 
alcohol swab prior to all blood draws.  Samples were labeled with corresponding 
subject identification numbers before being placed in a sealed and labeled 
biohazard bag (primary container) inside of a sealed and labeled biohazard 
cooler (secondary container).  Samples were kept in an ice bath until they were 
analyzed in accordance with the parameters described in the University of 
Nevada, Las Vegas Institutional Biosafety Manual (Section VIII, page 19). 
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Standard biological personal safety barriers including latex-free gloves, 
laboratory coat, and eye safety goggles were worn at all times by research team 
members.  All sharps and biological material were disposed of in a labeled and 
sealed sharps container and decontamination was conducted in accordance with 
the University of Nevada, Las Vegas Institutional Biosafety Manual (Section IX, 
page 23). 
Blood Sample Analysis 
 Each sample was transported to the Exercise Biochemistry Laboratory for 
DNA isolation and storage.  Whole blood (approximately 400 microliters) was 
added to 1000 microliters of Cell Lysis Solution, thoroughly mixed, and incubated 
for 10 minutes at room temperature. The sample was then centrifuged, and the 
supernatant was discarded without disturbing the white blood cell pellet. The 
cells were then re-suspended via vigorous vortexing and 400 microliters Nuclei 
Lysis Solution was added and incubated at 37ºC for 15-minutes. After allowing 
the sample to cool to room temperature, 110 microliters of Protein Precipitation 
Solution was added, vortexed, and then centrifuged. A dark brown protein pellet 
was visible at the bottom of the tube, and the remaining supernatant was 
transferred to a new microcentrifuge tube containing 300 microliters isopropanol. 
This tube was gently mixed and then centrifuged to pellet the DNA. The 
supernatant was discarded in a biohazard waste container, and equal volume of 
70% ethanol was added in a wash step before centrifugation. The tube was 
inverted over absorbent paper and allowed to air-dry for 15 minutes. DNA 
Rehydration Solution (20-100 L) was added to the tube and allowed to incubate 
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overnight at room temperature before being stored at 2-8 ºC for subsequent 
epigenetic analysis. DNA concentration (ng/mL) was determined using an Epoch 
microplate reader with the Take3 System (Biotek U.S., Winooski, VT) 
 Once all samples had been collected and purified using the process outlined 
above, the determination of global DNA methylation was achieved by the use of 
a commercially available assay kit (MethyFlash Methaylated DNA Quantification 
Kit, Epigentek Group Inc., Farmingdale, NY).  A binding solution, followed by the 
samples was added to an antibody-infused 96 well plate.  Negative and positive 
controls, as well as diluted positive values were added alongside the samples 
and tested in order to produce a standard curve for quantification proposes.  The 
samples were allowed to incubate for 90 minutes inside the wells.  Afterwards, 
the samples were removed, the wells were washed with a wash buffer, and a 
capture antibody was added to each well.  The plate then incubated again for 60 
minutes, at which time the solution was removed and a washer buffer was used 
again to clean the wells.  Following the second washing, a detection antibody 
was added and allowed to incubate for 30 minutes.  A third wash step took place 
after the 30 minutes.  An enhancer solution was then added to each well and a 
final 30 minute incubation phase was conducted.  A final wash step occurred 
followed by the addition of the developer solution, which turned the sample a 
bluish tint depending on the methylation level.  Finally, a stop solution was added 
before the 96 well plate was placed in a plate reader and read at 450 nm.   All 
samples were processed at the same time and global DNA methylation levels 
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were expressed as an absolute percentage based on the determined standard 
curve.  The formulas used are given below. 
         
                   
         
 
     
       
 
       
S is the concentration of sample DNA used in nano grams. 
 
Data Analysis Methods 
 A Pearson product-moment correlation coefficient (Pearson’s “r”) was used to 
determine the correlations between body composition, fitness measurements, 
and GDM percentage.  A series of t-tests were further conducted to determine 
any underlying differences.  High and low value groups from each variable were 
constructed and compared for significant differences.  The groups will be 
determined by whether they are higher or lower than the median for each 
variable.  The significance level was set at α = 0.05.  All statistical analyses were 
calculated using SPSS Version 20 (IBM Corporation, Armonk, NY). 
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CHAPTER 4   
 
RESULTS 
Correlations 
 A total of five different measures (percent body fat, body mass index, bone 
mineral density, VO2max [ml/kg/min], and the control measure of average folate 
intake) were examined for a relationship with GDM percentage.  Correlations 
were first analyzed as an overall group, followed by a by gender delineation.  
Total subject group analyses revealed no significant relationships with r values 
ranging from -0.001 to 0.198 (see Table 4.1).  Upon grouping the subject pool by 
gender, it was determined that BMI was significantly (r=-.556, p=.031) correlated 
with GDM percentage for females only.  Body fat percentage approached 
significance in females as well (r = 0.146, p=0.146).  No significant correlations 
were found in males for any of the variables. 
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Table 4.1 Correlation Results 
   
 
Pearson's r p-value 
Total Group   
  
 
Body Fat -0.173 0.397 
 
BMI -0.198 0.332 
 
BMD 0.0 0.874 
 
VO2max 0.0 0.995 
 
Folate 0.198 0.331 
Males 
 
  
 
Body Fat 0.101 0.767 
 
BMI 0.258 0.444 
 
BMD 0.371 0.262 
 
VO2max -0.253 0.452 
 
Folate 0.323 0.333 
Females 
   
 
Body Fat -0.394 0.146 
 
BMI -0.556 0.031* 
 
BMD 0.038 0.894 
 
VO2max 0.178 0.526 
  Folate 0.218 0.434 
*BMI was significantly correlated to GDM in 
Females. 
  
t-tests 
 To further investigate the possibility of a relationship between GDM 
percentage and the aforementioned variables, t-tests were conducted for 
potential differences between high scores verses lower values for any given 
variable.  The median values for percentage of body fat (21.45%), body mass 
index (24.02 kg/m2), bone mineral density (1.195g/cm2), VO2max (52.225 
ml/kg/min), and average folate intake were determined   (237.2 µg/day) and 
subjects were grouped according to whether they were higher or lower than the 
median value for each variable.  The t-tests revealed a significant difference in 
the percentage of GDM between those with higher levels of folate intake 
 32 
 
 
compared to those with lower levels (see Table 4.2).  The difference in GDM% 
between those with higher BMI values and lower BMI values approached 
significance, while no significant differences were detected between high and low 
groups for VO2max, bone mineral density, and percentage of body fat. 
Table 4.2 t-test Results 
    
  Median Group Methylation (%) 
p 
value ∆% 
      Mean SD     
BF% 21.45% 
High 2.835 1.220 
0.574 8.95465 
Low 2.602 0.819 
       
BMI 24.0 
High 2.375 0.914 
0.088 -22.4512 
Low 3.062 1.052 
 
      
BMD 
1.1955 
(g/cm2) 
High 2.692 0.822 
0.899 -1.91635 
Low 2.745 1.233 
       
Folate 
237.2 
(µg/day) 
High 3.139 1.168 
0.034* 36.63388 
Low 2.298 0.672 
       VO2 
Max 
52.23 
(ml/kg/min) 
High 2.647 1.244 
0.729 -5.16037 
Low 2.791 0.799 
*The High folate group has significantly increased GDM% 
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CHAPTER 5 
 
SUMMARY, CONCLUSIONS,  
AND RECOMMENDATIONS 
Discussion of Results 
 The purpose of this investigation was to determine whether a relationship 
exists between the percentage of global DNA methylation and measures of 
aerobic fitness, as well as measures of body composition. It was hypothesized 
that a significant correlation would exist between GDM% and measures of 
aerobic fitness and body composition. Regarding the association between VO2max 
and GDM%, we retain the null hypothesis as no significant correlation was 
determined. When considering the body composition measure of Body Mass 
Index, we found that a significant relationship existed with global DNA 
methylation percentage in the female group only. 
 Upon classifying the subjects by gender, it was determined that there was a 
negative correlation with BMI and GDM percentage in females.  These results 
disagree with the findings of Kim et al. (2010) in two ways.  First, the association 
found in the present study suggests that as BMI increases, GDM percentage 
decreases, while Kim et al. (2010) found the opposite.  Secondly, both males and 
females displayed a significant correlation in the Kim et al. (2010) study while 
only females did so presently.  Possible rationales for these inconsistencies are 
the facts that the Kim et al. (2010) study was conducted in Singapore, where the 
obesity rate is much lower than in the United States (12% versus 36% 
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respectively) and the fact that the present study had a much smaller sample size 
(n=26 vs n=286 comparatively).  This study was also unique in that it took an 
actual measurement of body composition (DEXA scan), as well as calculating 
BMI values.  
 Additionally, Kim et al. (2010) reported that global DNA methylation was 
significantly associated with an increased risk of cardiovascular disease. 
Specifically, they reported that males who developed cardiovascular disease 
(myocardial infarction, stroke) or its predisposing conditions (hypertension and 
diabetes) over a 5 year span had significantly higher levels of GMD compared to 
their disease free counterparts (p=0.03).  As it is well established that physical 
fitness level and aerobic capacity is inversely related with cardiovascular disease 
risk (Dencker et al., 2012; Shortreed, Peeters, & Forbes, 2013), it seemed 
intuitive that a measure of aerobic capacity (VO2max) would also be related to 
global DNA methylation. However, we found that VO2max was not significantly (r ≤ 
-0.253, p>0.452) related to GDM percentage in males or females, and there was 
no significant (p=0.729) difference between the high or low VO2max groups.  To 
our knowledge, this is the first investigation to report that there is no association 
between VO2max and GDM%.  As previously addressed, the low number of 
subjects, specifically sedentary subjects, in the present study could be an 
explanation for this lack of association.  While cardiovascular disease risk is 
positively impacted by one’s aerobic fitness, there are confounding factors that 
may affect the cardiovascular system, including smoking, dietary habits, and 
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family history.  Further research is necessary to determine whether other 
measures of aerobic fitness are more sensitive correlates with DNA methylation. 
 Regarding dietary habits, a measure of average folate intake was estimated 
in the current study participants. The results of the delineated t-tests 
demonstrated that nutritional status needs to be accounted for at all times with 
concerns to methylation levels.  The findings are in agreement with the concepts 
presented by Ong, Moreno, & Ross (2012) in that higher folate intake can 
influence methylation levels.  The article discusses the need for research on 
using bioactive foods (including those high in folate) as a cancer prevention 
method.  Foods high in folate were chosen due to folate’s role in the methylation 
process as a methyl group donor.  The present study demonstrates that 
individuals with elevated intakes of folate can have GDM percentages higher 
than those with low intakes of folate by 36.6%.  Though this was not the main 
concern of the present study, folate’s influence on GDM levels must be 
accounted for in future studies in order to limit confounding variables. 
 
Conclusions and Recommendations for Further Study 
 Most methylation studies, be them GDM or individual gene methylation 
studies, have subject pools numbering in the hundreds due to the innate variance 
in individual genomes.    As trends were evident with the small number of 
subjects in the present investigation, continued studies with a more diverse 
sample are warranted.  Sedentary or less physically fit subjects would increase 
the diversity of the study and more than likely strengthen the correlations. 
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 In addition to the pervious comment, it should be noted that at present time, 
there is no standard order or procedure for reporting GDM percentages.  The 
current study has an average GDM percentage of 2.7% which is similar to the 
findings displayed by McGuinness et al. (2012).  At the same time, GDM 
percentages have been published ranging from 0.85% (Liu et al., 2011) to 91% 
(Bromberg, Bersudsky, & Agam, 2009).  This large discrepancy could be due to 
the fact that various means of DNA isolation and GDM quantification were used 
by the studies, which has been shown to significantly affect the GDM 
percentages (Soriano-Tarraga et al., 2013).  This lack of standardization does 
not allow for easy comparisons between studies and can be very misleading 
when examining multiple studies.  Standards need to be established in order for 
future research to prosper. 
 To our knowledge, this is the first study to correlate a direct measure of body 
composition with GDM. While the small number of subjects was a serious limiting 
factor, a number of interesting findings were present.  It was demonstrated that 
an inverse relationship between GDM and BMI appears to be present in females, 
while not in males.  Additionally, individuals with an increased levels of folate 
consumption have elevated levels of GDM compared to those that intake 
decreased amounts of folate.  At this time, it does not appear that there is a 
relationship between cardiovascular fitness, measured by VO2max, and GDM.  
Additionally, studies with further measures of aerobic fitness and greater 
numbers of subjects are needed in order to definitively say that this relationship 
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does not exist.  DNA methlyation continues to be a biomarker of great 
importance in terms of detecting cardiovascular disease risk and prevention. 
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